DeVinney Erick Wayne
SEC CIK 1595972 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AXGN | Axogen, Inc. | VP Peripheral Nerve Science | 256.4K | — | $1.10M | 41 | 2021-07-19 | 2026-03-16 |
Most active insiders at AXGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Began Marc A | EVP, GC | — | $3.88M |
| 2 | Burke William P. Mr. | Dir | — | $2.82M |
| 3 | Weiler Kathy Johnson | Dir | — | $2.74M |
| 4 | DALE MICHAEL D | CEO | — | $2.67M |
| 5 | Wendell Amy McBride | Dir | — | $2.00M |
| 6 | JOHNSON JOHN | Dir | — | $1.87M |
| 7 | TYNDALL JOSEPH A. | Dir | — | $951.8K |
| 8 | Hartley Lindsey Marie | CFO | — | $942.2K |
| 9 | DeVinney Erick Wayne | Chief Innovation Off | — | $780.6K |
| 10 | THOMAS PAUL | Dir | — | $633.6K |
Transactions 41
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-18 | 2026-03-16 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | F - Tax | $32.84 | -2,870 | 256.4K | -1% | -$94.3K |
| DM | 2026-03-18 | 2026-03-16 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | M - OptEx | $0.00 | +17.9K | 268.0K | +7% | $0 |
| D | 2026-03-18 | 2026-03-16 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | S - Sale+OE | $32.84 | -5,221 | 262.8K | -2% | -$171.5K |
| DM | 2026-03-02 | 2026-02-26+ | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | F - Tax | $31.26 | -22.0K | 252.9K | -8% | -$687.0K |
| D | 2026-03-02 | 2026-02-26 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | A - Grant | $0.00 | +33.8K | 274.9K | +14% | $0 |
| 2025-12-10 | 2025-12-09 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | S - Sale | $31.21 | -19.5K | 241.1K | -7% | -$609.1K | |
| 2025-12-05 | 2025-12-04 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | A - Grant | $0.00 | +40.0K | 260.6K | +18% | $0 | |
| 2025-09-16 | 2025-09-16 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | S - Sale | $16.29 | -1,137 | 220.6K | -0.5% | -$18.5K | |
| 2025-09-16 | 2025-09-13 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | A - Grant | $0.00 | +2,500 | 221.8K | +1% | $0 | |
| DM | 2025-03-19 | 2025-03-16 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | M - OptEx | $0.00 | +32.5K | 232.9K | +16% | $0 |
| D | 2025-03-19 | 2025-03-19 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | S - Sale+OE | $17.50 | -15.1K | 217.8K | -6% | -$264.4K |
| 2025-03-04 | 2025-02-28 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | M - OptEx | $0.00 | +24.8K | 209.3K | +13% | $0 | |
| 2025-03-04 | 2025-03-04 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | F - Tax | $18.35 | -8,296 | 201.0K | -4% | -$152.2K | |
| 2025-02-26 | 2025-02-25 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | F - Tax | $16.50 | -972 | 184.5K | -0.5% | -$16.0K | |
| 2025-02-26 | 2025-02-22 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | A - Grant | $0.00 | +2,500 | 185.5K | +1% | $0 | |
| 2024-09-13 | 2024-09-13 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | A - Grant | $0.00 | +2,500 | 180.0K | +1% | $0 | |
| DM | 2024-03-25 | 2024-03-21 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | S - Sale+OE | $7.68 | -4,578 | 167.9K | -3% | -$35.2K |
| DM | 2024-03-25 | 2024-03-16 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | M - OptEx | $0.00 | +18.7K | 166.4K | +13% | $0 |
| 2024-03-05 | 2024-03-01 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | Chief Innovation Off | A - Grant | — | +50.0K | 163.4K | +44% | — | |
| 2023-10-13 | 2023-07-18 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | A - Grant | $0.00 | +1,579 | 114.2K | +1% | $0 | |
| 2023-10-13 | 2023-10-13 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | D - Sale to Iss | $4.04 | -864 | 113.4K | -0.8% | -$3,491 | |
| DM | 2023-03-20 | 2023-03-16 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $8.27 | -2,769 | 112.7K | -2% | -$22.9K |
| DM | 2023-03-20 | 2023-03-16 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | M - OptEx | $0.00 | +8,900 | 113.6K | +9% | $0 |
| D | 2022-12-29 | 2022-12-27 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $9.44 | -187 | 106.5K | -0.2% | -$1,765 |
| D | 2022-12-29 | 2022-12-27 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | M - OptEx | $0.00 | +750 | 106.7K | +0.7% | $0 |
| D | 2022-12-28 | 2022-12-27 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | M - OptEx | $5.09 | +20.0K | 116.8K | +21% | +$101.8K |
| D | 2022-12-28 | 2022-12-27 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $9.44 | -10.8K | 106.0K | -9% | -$101.8K |
| 2022-07-20 | 2022-07-18 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | A - Grant | $0.00 | +1,579 | 94.2K | +2% | $0 | |
| 2022-07-20 | 2022-07-19 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | D - Sale to Iss | $8.40 | -405 | 96.8K | -0.4% | -$3,402 | |
| D | 2022-03-18 | 2022-03-16 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | M - OptEx | $0.00 | +6,000 | 94.1K | +7% | $0 |
| D | 2022-03-18 | 2022-03-16 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $7.97 | -1,497 | 92.6K | -2% | -$11.9K |
| 2022-02-17 | 2022-02-15 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | A - Grant | $0.00 | +1,181 | 88.4K | +1% | $0 | |
| 2022-02-17 | 2022-02-15 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $8.42 | -357 | 88.1K | -0.4% | -$3,006 | |
| D | 2021-12-29 | 2021-12-27 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $9.74 | -187 | 87.2K | -0.2% | -$1,821 |
| D | 2021-12-29 | 2021-12-27 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | M - OptEx | $0.00 | +750 | 87.4K | +0.9% | $0 |
| D | 2021-12-22 | 2021-12-20 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $9.24 | -144 | 86.7K | -0.2% | -$1,331 |
| D | 2021-12-22 | 2021-12-20 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | M - OptEx | $0.00 | +575 | 86.8K | +0.7% | $0 |
| D | 2021-12-17 | 2021-12-15 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | M - OptEx | $3.67 | +10.0K | 90.4K | +12% | +$36.7K |
| D | 2021-12-17 | 2021-12-15 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $8.80 | -4,171 | 86.3K | -5% | -$36.7K |
| 2021-07-21 | 2021-07-19 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | A - Grant | $0.00 | +1,580 | 80.8K | +2% | $0 | |
| 2021-07-21 | 2021-07-20 | AXGN | Axogen, Inc. | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $19.20 | -392 | 80.4K | -0.5% | -$7,526 |
Purchase Sale Sale after option exercise All abbreviations